Skip to main content

Table 3 Completeness of data collection for planned outcomes in a main trial

From: Standard care informed by the result of a placental growth factor blood test versus standard care alone in women with reduced fetal movement at or after 36+0 weeks’ gestation: a pilot randomised controlled trial

Outcome

Control (n = 107)

Intervention (n = 109)

Total (n = 216)

Completeness of each component of proposed primary outcome

 Stillbirth or death before discharge

107 (100%)

109 (100%)

216 (100%)

 5-min Apgar score

107 (100%)

109 (100%)

216 (100%)

 Umbilical artery pH

62 (58%)

72 (66%)

134 (62%)

 Length of stay in neonatal unit

107 (100%)

109 (100%)

216 (100%)

Number of primary outcome components with complete data for each participant

 0

0 (–)

0 (–)

0 (–)

 1

0 (–)

0 (–)

0 (–)

 2

0 (–)

0 (–)

0 (–)

 3

45 (42%)

37 (34%)

82 (38%)

 4

62 (58%)

72 (66%)

134 (62%)

Participants with assessable composite primary outcome1

107 (100%)

109 (100%)

216 (100%)

  1. 1Primary outcome is assessable if all components are complete, or if any component is positive regardless of missing data, or if umbilical artery pH is missing and all other components are negative